{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:37:42Z","timestamp":1786120662339,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research and Development Program of Affiliated Hospital of North Sichuan Medical College","award":["2023-2GC011"],"award-info":[{"award-number":["2023-2GC011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04970-8","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:35:14Z","timestamp":1780479314000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ETV4 as a potential target gene for alleviating proliferation metastasis of HCC"],"prefix":"10.1186","volume":"26","author":[{"given":"Yuan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"3","key":"4970_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"4970_CR2","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","volume":"134","author":"W Cao","year":"2021","unstructured":"Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021;134(7):783\u201391. https:\/\/doi.org\/10.1097\/CM9.0000000000001474.","journal-title":"Chin Med J"},{"issue":"1","key":"4970_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1006\/bbrc.1997.6840","volume":"236","author":"CM Schmidt","year":"1997","unstructured":"Schmidt CM, McKillop IH, Cahill PA, Sitzmann JV. Increased MAPK Expression and Activity in Primary Human Hepatocellular Carcinoma. Biochem Biophys Res Commun. 1997;236(1):54\u20138. https:\/\/doi.org\/10.1006\/bbrc.1997.6840.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"4970_CR4","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.3390\/cancers13123026","volume":"13","author":"H Moon","year":"2021","unstructured":"Moon H, Ro SW. MAPK\/ERK Signaling Pathway in Hepatocellular Carcinoma. Cancers. 2021;13(12):3026. https:\/\/doi.org\/10.3390\/cancers13123026.","journal-title":"Cancers"},{"issue":"1","key":"4970_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-021-00245-6","volume":"7","author":"Hepatocellular carcinoma","year":"2021","unstructured":"Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):7. https:\/\/doi.org\/10.1038\/s41572-021-00245-6.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"4970_CR6","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1158\/0008-5472.CAN-19-1382","volume":"80","author":"AC Rodriguez","year":"2020","unstructured":"Rodriguez AC, Vahrenkamp JM, Berrett KC, Clark KA, Guillen KP, Scherer SD, et al. ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells. Cancer Res. 2020;80(6):1234\u201345. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1382.","journal-title":"Cancer Res"},{"issue":"1","key":"4970_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/mc.23130","volume":"59","author":"Y Wang","year":"2020","unstructured":"Wang Y, Ding X, Liu B, Li M, Chang Y, Shen H, et al. ETV4 overexpression promotes progression of non\u2013small cell lung cancer by upregulating PXN and MMP1 transcriptionally. Mol Carcinog. 2020;59(1):73\u201386. https:\/\/doi.org\/10.1002\/mc.23130.","journal-title":"Mol Carcinog"},{"issue":"1","key":"4970_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41420-021-00508-x","volume":"7","author":"T Zhu","year":"2021","unstructured":"Zhu T, Zheng J, Zhuo W, Pan P, Li M, Zhang W, et al. ETV4 promotes breast cancer cell stemness by activating glycolysis and CXCR4-mediated sonic Hedgehog signaling. Cell Death Discov. 2021;7(1):126. https:\/\/doi.org\/10.1038\/s41420-021-00508-x.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4970_CR9","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s12967-024-05356-8","volume":"22","author":"J Zhang","year":"2024","unstructured":"Zhang J, Wang Q, Qi S, Duan Y, Liu Z, Liu J, et al. An oncogenic enhancer promotes melanoma progression via regulating ETV4 expression. J Transl Med. 2024;22(1):547. https:\/\/doi.org\/10.1186\/s12967-024-05356-8.","journal-title":"J Transl Med"},{"issue":"14","key":"4970_CR10","doi-asserted-by":"publisher","first-page":"eadc9446","DOI":"10.1126\/sciadv.adc9446","volume":"9","author":"D Li","year":"2023","unstructured":"Li D, Zhan Y, Wang N, Tang F, Lee CJ, Bayshtok G, et al. ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer. Sci Adv. 2023;9(14):eadc9446. https:\/\/doi.org\/10.1126\/sciadv.adc9446.","journal-title":"Sci Adv"},{"key":"4970_CR11","doi-asserted-by":"publisher","unstructured":"ZhangQ, Liu S, Wang H, Xiao K, Lu J, Chen S et al. ETV4 Mediated Tumor-Associated Neutrophil Infiltration Facilitates Lymphangiogenesis and Lymphatic Metastasis of Bladder Cancer. Adv Sci. 2023. https:\/\/doi.org\/10.1002\/advs.202205613","DOI":"10.1002\/advs.202205613"},{"issue":"1","key":"4970_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jhep.2023.04.005","volume":"79","author":"AJ Craig","year":"2023","unstructured":"Craig AJ, Silveira MAD. The role of ETV4 in HCC: How transcription factors can inform immunotherapy combination treatments. J Hepatol. 2023;79(1):19\u201321. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.005.","journal-title":"J Hepatol"},{"issue":"1","key":"4970_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jhep.2023.02.036","volume":"79","author":"M Xie","year":"2023","unstructured":"Xie M, Lin Z, Ji X, Luo X, Zhang Z, Sun M, et al. FGF19\/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2. J Hepatol. 2023;79(1):109\u201325. https:\/\/doi.org\/10.1016\/j.jhep.2023.02.036.","journal-title":"J Hepatol"},{"issue":"12","key":"4970_CR14","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/cac2.12482","volume":"43","author":"D Qi","year":"2023","unstructured":"Qi D, Lu M, Xu P, Yao X, Chen Y, Gan L, et al. Transcription factor ETV4 promotes the development of hepatocellular carcinoma by driving hepatic TNF-\u03b1 signaling. Cancer Commun. 2023;43(12):1354\u201372. https:\/\/doi.org\/10.1002\/cac2.12482.","journal-title":"Cancer Commun"},{"issue":"1","key":"4970_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12935-020-01700-2","volume":"21","author":"Y Leng","year":"2021","unstructured":"Leng Y, Chen Z, Ding H, Zhao X, Qin L, Pan Y. Overexpression of microRNA-29b inhibits epithelial-mesenchymal transition and angiogenesis of colorectal cancer through the ETV4\/ERK\/EGFR axis. Cancer Cell Int. 2021;21(1):17. https:\/\/doi.org\/10.1186\/s12935-020-01700-2.","journal-title":"Cancer Cell Int"},{"key":"4970_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9423907","volume":"2019","author":"C Scheau","year":"2019","unstructured":"Scheau C, Badarau IA, Costache R, Caruntu C, Mihai GL, Didilescu AC, et al. The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma. Anal Cell Pathol. 2019;2019:1\u201310. https:\/\/doi.org\/10.1155\/2019\/9423907.","journal-title":"Anal Cell Pathol"},{"issue":"2","key":"4970_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.21873\/cgp.20024","volume":"14","author":"The Contribution of Matrix","year":"2017","unstructured":"The Contribution of Matrix. Metalloproteinase-1 Genotypes to Hepatocellular Carcinoma Susceptibility in Taiwan. CGP. 2017;14(2):119\u201326. https:\/\/doi.org\/10.21873\/cgp.20024.","journal-title":"CGP"},{"issue":"7","key":"4970_CR18","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3390\/cancers14071847","volume":"14","author":"K Augoff","year":"2022","unstructured":"Augoff K, Hryniewicz-Jankowska A, Tabola R, Stach K. MMP9: A Tough Target for Targeted Therapy for Cancer. Cancers. 2022;14(7):1847. https:\/\/doi.org\/10.3390\/cancers14071847.","journal-title":"Cancers"},{"issue":"10","key":"4970_CR19","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.3390\/s18103249","volume":"18","author":"H Huang","year":"2018","unstructured":"Huang H. Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances. Sensors. 2018;18(10):3249. https:\/\/doi.org\/10.3390\/s18103249.","journal-title":"Sensors"},{"key":"4970_CR20","unstructured":"XiaohuiC, Xin L, Dehua W. E26 transformation-specific variant 4 promotes sorafenib and cisplatin resistance in hepatocellular carcinoma cells in vitro. https:\/\/www.researchsquare.com\/article\/rs-23286\/v1"},{"issue":"3","key":"4970_CR21","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3892\/ol.2017.5557","volume":"13","author":"S Yang","year":"2017","unstructured":"Yang S, Liu G. Targeting the Ras\/Raf\/MEK\/ERK pathway in hepatocellular carcinoma. Oncol Lett. 2017;13(3):1041\u20137. https:\/\/doi.org\/10.3892\/ol.2017.5557.","journal-title":"Oncol Lett"},{"issue":"1","key":"4970_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/1476-4598-9-313","volume":"9","author":"R Keld","year":"2010","unstructured":"Keld R, Guo B, Downey P, Gulmann C, Ang YS, Sharrocks AD. The ERK MAP kinase-PEA3\/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma. Mol Cancer. 2010;9(1):313. https:\/\/doi.org\/10.1186\/1476-4598-9-313.","journal-title":"Mol Cancer"},{"issue":"3","key":"4970_CR23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/path.4728","volume":"239","author":"TM Fung","year":"2016","unstructured":"Fung TM, Ng KY, Tong M, Chen J, Chai S, Chan K, et al. Neuropilin-2 promotes tumourigenicity and metastasis in oesophageal squamous cell carcinoma through ERK\u2013MAPK\u2013ETV4\u2013MMP \u2013E\u2010cadherin deregulation. J Pathol. 2016;239(3):309\u201319. https:\/\/doi.org\/10.1002\/path.4728.","journal-title":"J Pathol"},{"issue":"4","key":"4970_CR24","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1530\/REP-22-0184","volume":"165","author":"Q Jie","year":"2023","unstructured":"Jie Q, Chen L, Liang J, Yang X, Sun F, Ma Y. Downregulated ETV4 inhibits the proliferation, migration, and invasion of trophoblast cells in preeclampsia. Reproduction. 2023;165(4):373\u201381. https:\/\/doi.org\/10.1530\/REP-22-0184.","journal-title":"Reproduction"},{"issue":"7","key":"4970_CR25","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3390\/ijms21072346","volume":"21","author":"J Yue","year":"2020","unstructured":"Yue J, L\u00f3pez JM. Understanding MAPK Signaling Pathways in Apoptosis. IJMS. 2020;21(7):2346. https:\/\/doi.org\/10.3390\/ijms21072346.","journal-title":"IJMS"},{"key":"4970_CR26","unstructured":"Hoffmann K, Shibo L, Xiao Z, Longerich T, B\u00fcchler MW, Schemmer P. Correlation of Gene Expression of ATP-binding Cassette Protein and Tyrosine Kinase Signaling Pathway in Patients with Hepatocellular Carcinoma. ANTICANCER RESEARCH; 2011."},{"issue":"1","key":"4970_CR27","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1186\/s12885-018-4761-3","volume":"18","author":"W Liu","year":"2018","unstructured":"Liu W, Fan Y, Shi Y, Lin Z, Huang X, Huang W, et al. Knockdown of TIPE2 increases the proliferation in lipopolysaccharide-stimulated gastric cancer cells. BMC Cancer. 2018;18(1):857. https:\/\/doi.org\/10.1186\/s12885-018-4761-3.","journal-title":"BMC Cancer"},{"key":"4970_CR28","doi-asserted-by":"publisher","first-page":"145579","DOI":"10.1016\/j.ijbiomac.2025.145579","volume":"320","author":"LL Gao","year":"2025","unstructured":"Gao LL, Jia D, Shi JQ, Zhang JC, Lu LX, Wei M, et al. Acteoside suppresses hepatocellular carcinoma progression via modulation of macrophage migration inhibitory factor and mitogen-activated protein kinase proteins. Int J Biol Macromol. 2025;320:145579. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145579.","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"4970_CR29","doi-asserted-by":"publisher","first-page":"BSR20193137","DOI":"10.1042\/BSR20193137","volume":"40","author":"L Yang","year":"2020","unstructured":"Yang L, Hu Y, Zhou G, Chen Q, Song Z. Erianin suppresses hepatocellular carcinoma cells through down-regulation of PI3K\/AKT, p38 and ERK MAPK signaling pathways. Biosci Rep. 2020;40(7):BSR20193137. https:\/\/doi.org\/10.1042\/BSR20193137.","journal-title":"Biosci Rep"},{"issue":"12","key":"4970_CR30","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1002\/cam4.1228","volume":"6","author":"Y Liang","year":"2017","unstructured":"Liang Y, Chen J, Yu Q, Ji T, Zhang B, Xu J, et al. Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma. Cancer Med. 2017;6(12):2787\u201395. https:\/\/doi.org\/10.1002\/cam4.1228.","journal-title":"Cancer Med"},{"issue":"6","key":"4970_CR31","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1002\/hep.29738","volume":"67","author":"E Kim","year":"2018","unstructured":"Kim E, Kim D, Lee J, Yoe J, Park J, Kim C, et al. Capicua suppresses hepatocellular carcinoma progression by controlling the ETV4\u2013MMP1 axis. Hepatology. 2018;67(6):2287\u2013301. https:\/\/doi.org\/10.1002\/hep.29738.","journal-title":"Hepatology"},{"issue":"1","key":"4970_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12876-025-04485-8","volume":"26","author":"YH Kang","year":"2025","unstructured":"Kang YH, Chen RS, Hu Q, Sun HT, Guo P, Lv SL, et al. Clinical significance of the S204 phosphorylation of the Smad3 protein in combination with Ki67 for the metastasis and prognosis of gastric cancer. BMC Gastroenterol. 2025;26(1):37. https:\/\/doi.org\/10.1186\/s12876-025-04485-8.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"4970_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13045-016-0307-9","volume":"9","author":"A Jayachandran","year":"2016","unstructured":"Jayachandran A, Dhungel B, Steel JC. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma. J Hematol Oncol. 2016;9(1):74. https:\/\/doi.org\/10.1186\/s13045-016-0307-9.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"4970_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 2023;42(3):629\u201352. https:\/\/doi.org\/10.1007\/s10555-023-10084-4.","journal-title":"Cancer Metastasis Rev"},{"issue":"37","key":"4970_CR35","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.3748\/wjg.v19.i37.6144","volume":"19","author":"JW Shin","year":"2013","unstructured":"Shin JW. Molecular targeted therapy for hepatocellular carcinoma: Current and future. WJG. 2013;19(37):6144. https:\/\/doi.org\/10.3748\/wjg.v19.i37.6144.","journal-title":"WJG"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04970-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04970-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:30:19Z","timestamp":1786062619000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04970-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4970"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04970-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"8 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by Ethics Committee of the Affiliated Hospital of North Sichuan Medical College.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"491"}}